Related Experiment Video
Updated: Oct 23, 2025

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
ePharmer: An integrated and graphical software for pharmacophore-based virtual screening.
Yuxia Mao1, Shiliang Li2, Bojie Gong3
1School of Computer Science and Technology, East China Normal University, Shanghai, China.
ePharmer is new software for pharmacophore-based virtual screening (VS). It offers integrated ligand and structure-based methods with a user-friendly interface, improving drug design efficiency for experts and non-experts.
Area of Science:
- Computational chemistry
- Drug discovery
- Bioinformatics
Background:
- Pharmacophore-based virtual screening (VS) is crucial for drug design, especially for targets with unknown structures.
- Existing software lacks integrated methods and user-friendly interfaces.
Purpose of the Study:
- To develop a stand-alone, integrated, graphical software for pharmacophore-based VS named ePharmer.
- To enhance the efficiency and accessibility of virtual screening for drug design.
Main Methods:
- Integrated ligand-based and structure-based pharmacophore generation.
- Developed a layered architecture (computing, integration, visualization) with a graphical user interface.
- Included metabolite prediction for experimental preselection.
Main Results:
- ePharmer provides a user-friendly interface for pharmacophore modeling, analysis, and VS.
- The software integrates diverse computational methods for efficient drug design.
- Experimental results confirmed ePharmer's computational capability, usability, and performance.
Conclusions:
- ePharmer offers a comprehensive and user-friendly solution for pharmacophore-based virtual screening.
- The software is suitable for both professional researchers and non-expert users.
- ePharmer is expected to accelerate the drug discovery process.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025